Clinical trial
Influence of Enteral Microbiome Composition and Microbiome Dependent Metabolites on Mortality of Patients With Cardiogenic Shock
NCT06006754 is registered in ClinicalTrials.gov with University Hospital, Essen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Influence of Enteral Microbiome Composition and Microbiome Dependent Metabolites on Mortality of Patients With Cardiogenic Shock
- Lead sponsor
- University Hospital, Essen
- Phase
- Observational
- Overall status
- Completed
- Start date
- August 30, 2023
- Completion date
- February 15, 2025
- Enrollment
- 40 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute heart failure, acute myocardial infarction, cardiogenic shock, microbial colonization, out-of-hospital cardiac arrest